<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cell J</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell J</journal-id>
<journal-id journal-id-type="publisher-id">Royan Institute</journal-id>
<journal-title-group>
<journal-title>Cell Journal (Yakhteh)</journal-title>
</journal-title-group>
<issn pub-type="ppub">2228-5806</issn>
<issn pub-type="epub">2228-5814</issn>
<publisher>
<publisher-name>Royan Institute</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29845786</article-id>
<article-id pub-id-type="pmc">6004991</article-id>
<article-id pub-id-type="other">Cell-J-20-333</article-id>
<article-id pub-id-type="doi">10.22074/cellj.2018.5238</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
<subj-group>
<subject>Genetics</subject>
<subject>Cellular and Molecular Biology</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial Variants in Pompe Disease: A Comparison between
Classic and Non-Classic Forms</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bahreini</surname>
<given-names>Fatemeh</given-names>
</name>
<degrees>Ph.D</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Houshmand</surname>
<given-names>Massoud</given-names>
</name>
<degrees>Ph.D</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Modarressi</surname>
<given-names>Mohammad Hossein</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akrami</surname>
<given-names>Seyed Mohammad</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="A1"><label>1</label>Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
</aff>
<aff id="A2"><label>2</label>Department of Molecular Medicine and Genetics, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
</aff>
<aff id="A3"><label>3</label>Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran </aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*Corresponding Address:</label><addr-line>P.O.Box: 14176-13151</addr-line><addr-line>Department of Medical Genetics</addr-line><addr-line>School of Medicine</addr-line><institution>Tehran University of
Medical Sciences</institution><addr-line>Keshavarz BLV</addr-line><addr-line>Poursina St.</addr-line><addr-line>Tehran</addr-line><country>Iran</country>
Email:<email>akramism@tums.ac.ir</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Autumn</season>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>20</volume>
<issue>3</issue>
<fpage>333</fpage>
<lpage>339</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited</copyright-statement>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
<license-p>This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p> Pompe disease (PD) is a progressive neuromuscular disorder that is caused by glucosidase acid alpha (GAA)
deleterious mutations. Mitochondrial involvement is an important contributor to neuromuscular diseases. In this study the
sequence of <italic>MT-ATP 6/8</italic> and Cytochrome C oxidase <italic>I/II</italic> genes along with the expression levels of the former genes were
compared in classic and non-classic patients.
</p>
</sec>
<sec>
<title>Materials and Methods</title>
<p> In this case-control study, the sequence of <italic>MT-ATP 6/8</italic> and Cytochrome C oxidase was
analyzed by polymerase chain reaction (PCR)-Sanger sequencing and expression of <italic>MT-ATP</italic> genes were quantified
by real time-PCR (RT-PCR) in 28 Pompe patients. The results were then compared with 100 controls. All sequences
were compared with the revised Cambridge reference sequence as reference.
</p>
</sec>
<sec>
<title>Results</title>
<p> Screening of <italic>MT-ATP6/8</italic> resulted in the identification of three novel variants, namely T9117A, A8456C and
A8524C. There was a significant decrease in <italic>MT-ATP6</italic> expression between classic (i.e. adult) and control groups
(P=0.030). Additionally, the MT-ATP8 expression was significantly decreased in classic (P=0.004) and non-classic
(i.e. infant) patients (P=0.013). In total, 22 variants were observed in <italic>Cytochrome C oxidase</italic>, five of which were non-
synonymous, one leading to a stop codon and another (C9227G) being a novel heteroplasmic variant. The A8302G in
the lysine tRNA gene was found in two brothers in a pedigree, while a T7572C variant in the aspartate tRNA gene was
observed in two brothers in another pedigree.
</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The extent of mitochondrial involvement in the classic group was more significant than in the non-classic
form. Beside <italic>GAA</italic> deleterious mutations, it seems that mtDNA variants have a secondary effect on PD. Understanding,
the role of mitochondria in the pathogenesis of Pompe may potentially be helpful in developing new therapeutic
strategies.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Alpha-Glucosidase</kwd>
<kwd>Cytochrome-C Oxidase</kwd>
<kwd>Mitochondria</kwd>
<kwd>Pompe</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>Citation</meta-name>
<meta-value>Bahreini F, Houshmand M, Modarressi MH, Akrami SM. Mitochondrial variants in pompe disease: a comparison between classic and non-classic
forms. Cell J. 2018; 20(3): 333-339. doi: 10.22074/cellj.2018.5238.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Pompe disease (PD, OMIM #232300) is a progressive 
myopathy with an autosomal recessive mode of inheritance 
(<xref ref-type="bibr" rid="B1">1</xref>). The combined incidence of PD is generally 1 in 
40,000 (<xref ref-type="bibr" rid="B2">2</xref>). It has two common forms (early-onset/classic 
and late-onset/non-classic) with differences in degree 
of disease severity, age of onset and organ involvement 
(<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). The patients present a broad spectrum of clinical 
variability such as cardiomyopathy, hypotonia and 
respiratory insufficiency (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>They suffer from deficiency or lack of acid alphaglucosidase 
enzyme (<italic>GAA</italic>) that arise as a result of various 
deleterious variants in <italic>GAA</italic> (<xref ref-type="bibr" rid="B1">1</xref>). Genotype-phenotype 
correlation studies among patients with the same mutation 
in <italic>GAA</italic> have revealed different clinical manifestations (<xref ref-type="bibr" rid="B2">2</xref>). 
It seems that this diversity may be a result of interaction 
of other genetic and non-genetic factors. The sign and 
symptoms that are observed in Pompe patients are similar 
to those in mitochondrial disorders.</p>
<p>According to previous reports, mitochondrial dysfunction
can affect the neuromuscular system (<xref ref-type="bibr" rid="B7">7</xref>). Mitochondria (mt)
are essential to aerobic respiration by producing adenosine
triphosphate (ATP). The function of mt is controlled by both 
the mtDNA and nuclear genomes, and mtDNA variants may 
be affected by nuclear genome variants or vice versa (<xref ref-type="bibr" rid="B8">8</xref>). It is 
therefore possible that mtDNA genes interact with GAA. To 
test this hypothesis, <italic>MT-ATP6/8</italic> and <italic>Cytochrome C oxidase 
I/II</italic> 
were screened for functional variants, and the expression 
level of the former genes were analyzed in early and late-
onset PD patients.</p>
</sec>
<sec sec-type="materials-methods">
<title>Materials and Methods</title>
<p>In this case-control study, we recruited 28 PD patients (17 
infants and 11 adults) from the Department of Neurology of 
both Shariati and Mofid hospitals from December 2013 to 
February 2015. In this study, 100 healthy controls were also 
recruited comprising 17 infants and 83 adults. An informed 
consent was obtained from each participant or a parent in 
the case of infants. PD was diagnosed based on clinical 
findings by two expert neurologists, measurement of <italic>GAA</italic>
biochemical activity or detection of deleterious variants
in <italic>GAA</italic>. The included patients had no family history of 
mitochondrial or major neuromuscular disorders. This study
was approved by the Ethical Committee of Tehran University 
of Medical Sciences (92-02-30-23162). </p>
</sec>
<sec>
<title>DNA/RNA extraction </title>
<p>DNA was extracted from whole blood by using QIAamp 
DNA Blood Mini Kit (QIAGEN, Germany) according to 
the manufacturer’s instructions. Quantity and quality of 
DNA were checked by NanoDrop ND-1000 (NanoDrop 
Technologies, USA) at 260/280 nm wavelengths and running 
on an agarose gel (1%) respectively. Total RNAwas extracted 
from fresh whole blood samples by using the Hybrid-RTM 
Blood RNA kit and following its protocol (see http://www. 
tribioscience.com/files/315-150.pdf). RNA concentration 
and integrity were measured by NanoDrop and agarose gel 
respectively prior to cDNA synthesis. Presence of sharp 
bands for both 18S and 28S rRNA was checked. Purified 
RNA was then stored at -80°C.</p>
</sec>
<sec>
<title>cDNA synthesis</title>
<p>Total RNA was used to synthesize cDNA by using the 
cDNA synthesis kit (Fermentas, Germany) according to 
manufacturer’s instructions. Briefly, 2 µg of total RNA, 
1 µL of oligo dT and random hexamer primers and 8 µL 
nuclease-free water were mixed in a sterile, nuclease-
free tube and placed on ice. After incubation at 65°C for 
5 minutes, it was chilled on ice and 4 µL of 5X reaction 
buffer, 1 µL of RiboLock RNase Inhibitor (20 U/µL), 2 
µL of 10 mM dNTP mix, 1 µL of RevertAid M-MuLV RT 
(200 U/µL) were added. </p>
<p>The mixture was centrifuged briefly and incubated for 
5 minutes at 25°C followed by 60 minutes at 42°C. The 
reaction terminated by heating at 70°C for 5 minutes and 
stored at -80°C until further use.</p>
</sec>
<sec>
<title>Variant detection </title>
<p>Polymerase chain reaction (PCR) was performed with 
primers specific to <italic>MT- ATP6/8, Cytochrome C</italic> oxidase 
and their flanking sequences (<xref ref-type="table" rid="T1">Table 1</xref>) (<xref ref-type="bibr" rid="B8">8</xref>). </p>
<p>The PCR reaction included 50 ng of genomic DNA, 1 µL 
of each primer (10 pmol), 0.2 mM of each deoxynucleoside 
triphosphate (dNTP), 1.5 mM MgCl<sub>2</sub> and 1 U of Taq 
polymerase (CinnaGen, Inc, Iran). Cycling conditions for 
all PCR reactions were an initial denaturation at 94°C for 
4 minutes, followed by 35 cycles of denaturation at 94°C 
for 35 seconds, annealing at 56° for 35 seconds, extension 
at 72°C for 35 seconds, and a final extension at 72°C for 5 
minutes. PCR-amplified fragments were sequenced by 
Macrogen (South Korea) using the same PCR primers in 
both directions along with a series of overlapping primers to 
cover all regions of interest for more accurate results. Finch 
TV version 1.4 (Geospiza, Inc., USA) was used to analyze 
the chromatograms and were then checked using BLAST 
(<uri xlink:href="https://blast.ncbi.nlm.nih.gov">https://blast.ncbi.nlm.nih.gov</uri>). The results were compared 
with the revised Cambridge reference sequence MITOMAP
(<uri xlink:href="www.mitomap.org">www.mitomap.org</uri>) and the 1000 Genome databases. 
Presence of variants was also checked in controls which were 
selected from different Iranian ethnicities. Furthermore, the 
effect of missense variants on protein structure was assessed 
by Polyphen-2 (<uri xlink:href="http://genetics.bwh.harvard.edu/pph2">http://genetics.bwh.harvard.edu/pph2</uri>) and 
CADD (Combined Annotation Depedent Depletion; <uri xlink:href="http://cadd.gs.washington.edu/score">http://
cadd.gs.washington.edu/score</uri>) scores. </p>
</sec>
<sec>
<title><italic>MT-ATP</italic> 6/8 expression analysis</title>
<p>
Expression levels of <italic>MT-ATP 6/8</italic> were quantified using a 
quantitative PCR (qPCR) assay. In brief, expression values 
were normalized relative to a housekeeping gene (<italic>ß-actin</italic>)
to calculate the relative gene expression based on the 2<sup>-ΔΔCt</sup> 
method (<xref ref-type="bibr" rid="B9">9</xref>). Details of primers are given in Table 2.</p>
<p>qPCR reactions were performed on a Corbett 6000 
PCR-Real-time Detection System with a total volume of 
20 µl reaction mixture, containing 1 µl DNA template (50 
ng), 10 µl SYBR Green PCR Master Mix (Takara, Japan), 
8 µl nuclease- free water and 0.5 µl of each primer (10 
pmol). The cycling conditions were an initial denaturation 
step at 95ºC for 30 seconds followed by 40 cycles of a 
denaturation step at 95ºC for 12 seconds and an annealing 
step at 58ºC for 35 seconds. Melting curve analysis was 
used to validate the specificity and identity of the PCR 
product for each primer pair. Each sample was run in 
duplicate to ensure the reliability of the results. Also, a 
non-template control was included in each qPCR run. </p>
</sec>
<sec>
<title>Statistical analysis </title>
<p>Quantitative variables, in the form of frequency, such as 
participant characteristics and mitochondrial involvement 
were described as mean ± SD. Fisher’s exact test was used 
to compare frequency of mitochondrial involvement in PD 
and control groups. P&lt;0.05 was considered statistically 
significant. All analyses were implemented in SPSS 
version 16 (IBM, USA). Bonferroni’s multiple-testing 
correction was used to adjust the significance level (a). 
For frequency comparison of the identified 14 variants, a 
was set to 0.0036. For differential expression, given that 
two genes were compared, a was set to 0.025. </p>
</sec>
<sec sec-type="results">
<title>Results</title>
<p>Screening of MT-ATP6/8 in patients resulted in the 
identification of 14 variants, of which three were novel 
variants (<xref ref-type="fig" rid="F1">Fig .1</xref>). Of the total, 7 variants were in the 
classic group, 4 in the non-classic group and 3 were 
shared between the two groups (<xref ref-type="table" rid="T1">Table 1</xref>). There were 
four synonymous and ten non synonymous variants in 
<italic>MT-ATPase6/8</italic> (<xref ref-type="table" rid="T1">Table 1</xref>). The variants not previously 
reported in MITOMAP (<uri>WWW.mitomap.org</uri>) and other 
variant databases (e.g. the 1000 Genome database), were 
checked in controls. Frequencies of A8524C and C8562T 
were significantly different between patients and controls 
(P=0.047). A8860G, A8524C and C8562T were observed 
in 85.71, 7.14 and 7.14% of patients, respectively. The 
Polyphen-2 and CADD scores of missense variants 
showed in the Table 2. </p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p> Comparison of MT-ATP6/8 gene variants in PD and control groups</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<th colspan="9" rowspan="1">
<hr/>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1">Infant/Adult</th>
<th colspan="1" rowspan="1">Nucleotide</th>
<th colspan="1" rowspan="1">Locus</th>
<th colspan="1" rowspan="1">Amino acid change</th>
<th colspan="1" rowspan="1">R/N.R</th>
<th colspan="1" rowspan="1">Hm/Ht</th>
<th colspan="1" rowspan="1">Pompe</th>
<th colspan="1" rowspan="1">Control</th>
<th colspan="1" rowspan="1">P value</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1">+</th>
<th colspan="1" rowspan="1">+</th>
<th colspan="1" rowspan="1"></th>
</tr>
<tr>
<th colspan="9" rowspan="1">
<hr/>
</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Adult</td>
<td colspan="1" rowspan="1">C8406T</td>
<td colspan="1" rowspan="1">MT-ATPase8</td>
<td colspan="1" rowspan="1">p.T14I</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">A8456C</td>
<td colspan="1" rowspan="1">MT-ATPase6/8</td>
<td colspan="1" rowspan="1">p.T31P</td>
<td colspan="1" rowspan="1">N.R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">G9039A</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.M171I</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">G9055A</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.A177T</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">0.99</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Infant</td>
<td colspan="1" rowspan="1">A8502T</td>
<td colspan="1" rowspan="1">MT-ATPase8</td>
<td colspan="1" rowspan="1">p.N46I</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C8562T</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.P66L </td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.047</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C8562T</td>
<td colspan="1" rowspan="1">MT-ATPase8</td>
<td colspan="1" rowspan="1">p.P66P</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.047</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C8684T</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.T53I</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">0.650</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">G8697A</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.M57I</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">T9117A</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.I197I</td>
<td colspan="1" rowspan="1">N.R</td>
<td colspan="1" rowspan="1">Ht</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C9129T</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.I201I</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Both</td>
<td colspan="1" rowspan="1">A8524C</td>
<td colspan="1" rowspan="1">MT-ATPase8</td>
<td colspan="1" rowspan="1">p.P53P</td>
<td colspan="1" rowspan="1">N.R</td>
<td colspan="1" rowspan="1">Ht</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.047</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">A8701G</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.T59A</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">0.556</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">A8860G</td>
<td colspan="1" rowspan="1">MT-ATPase6</td>
<td colspan="1" rowspan="1">p.T112A</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">24</td>
<td colspan="1" rowspan="1">81</td>
<td colspan="1" rowspan="1">0.235</td>
</tr>
<tr>
<th colspan="9" rowspan="1">
<hr/>
</th>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>R and N.R; Denote reported and not-reported respectively, Hm and Ht; Denote homoplasmy and heteroplasmy respectively, and PD; Pompe disease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<p> Predicted effect of missense variants on protein structure</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<th colspan="5" rowspan="1">
<hr/>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1">Gene</th>
<th colspan="1" rowspan="1">Nucleotide position</th>
<th colspan="1" rowspan="1">Polyphen-2 score</th>
<th colspan="1" rowspan="1">CADD score</th>
<th colspan="1" rowspan="1">Prediction effect</th>
</tr>
<tr>
<th colspan="5" rowspan="1">
<hr/>
</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">7805</td>
<td colspan="1" rowspan="1">0.00</td>
<td colspan="1" rowspan="1">0.01</td>
<td colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">7859</td>
<td colspan="1" rowspan="1">0.00</td>
<td colspan="1" rowspan="1">0.50</td>
<td colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-ATP8</td>
<td colspan="1" rowspan="1">8406</td>
<td colspan="1" rowspan="1">0.08</td>
<td colspan="1" rowspan="1">0.16</td>
<td colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-ATP8</td>
<td colspan="1" rowspan="1">8456</td>
<td colspan="1" rowspan="1">0.02</td>
<td colspan="1" rowspan="1">3.82</td>
<td colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-ATP8</td>
<td colspan="1" rowspan="1">8502</td>
<td colspan="1" rowspan="1">0.99</td>
<td colspan="1" rowspan="1">18.47</td>
<td colspan="1" rowspan="1">Damaging</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-ATP6</td>
<td colspan="1" rowspan="1">8701</td>
<td colspan="1" rowspan="1">0.00</td>
<td colspan="1" rowspan="1">0.09</td>
<td colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-ATP6</td>
<td colspan="1" rowspan="1">9039</td>
<td colspan="1" rowspan="1">0.89</td>
<td colspan="1" rowspan="1">18.04</td>
<td colspan="1" rowspan="1">Damaging</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-ATP6</td>
<td colspan="1" rowspan="1">9055</td>
<td colspan="1" rowspan="1">0.84</td>
<td colspan="1" rowspan="1">22.60</td>
<td colspan="1" rowspan="1">Damaging</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-CO3</td>
<td colspan="1" rowspan="1">9336</td>
<td colspan="1" rowspan="1">0.00</td>
<td colspan="1" rowspan="1">0.01</td>
<td colspan="1" rowspan="1">Benign</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-CO3</td>
<td colspan="1" rowspan="1">9949</td>
<td colspan="1" rowspan="1">0.99</td>
<td colspan="1" rowspan="1">23.60</td>
<td colspan="1" rowspan="1">Damaging</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MT-CO3</td>
<td colspan="1" rowspan="1">9963</td>
<td colspan="1" rowspan="1">1.00</td>
<td colspan="1" rowspan="1">23.70</td>
<td colspan="1" rowspan="1">Damaging</td>
</tr>
<tr>
<th colspan="5" rowspan="1">
<hr/>
</th>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" orientation="portrait" position="float">
<label>Fig.1</label>
<caption>
<p>Chromatogram of the three novel variants in Mt.ATPase6/8 genes.
A. T9117A, p.I197I, Heteroplasmy, B. A8456C, p.T31P, Homoplasmy, and C. 
A8524C, p.P53P, Heteroplasmy. </p>
</caption>
<graphic xlink:href="Cell-J-20-333-g01"></graphic>
</fig>
</sec>
<sec>
<title><italic>MT-ATP6/8</italic> genes expression</title>
<p>A significant decrease was observed for <italic>MT-ATP6</italic> 
expression inclassic group compared with the 
control group. In addition, <italic>MT-ATP8</italic> 
expression was 
significantly decreased in the classic (P=0.004) and 
non-classic (P=0.013) patient groups compared with 
their controls.</p>
</sec>
<sec>
<title><italic>MT-Cytochrome C</italic> oxidase</title>
<p>Screening of MT-Cytochrome <italic>C oxidase</italic> led to the 
observation of 22 variants which C9227G sequence 
being a new heteroplasmic variant (<xref ref-type="fig" rid="F2">Fig .2</xref>). Fifteen and 
five variants were identified in the classic and non-classic 
groups respectively, while two variants were shared 
between the two groups. Furthermore, 5 variants were 
non-synonymous, 15 synonymous with one stop codon 
(<xref ref-type="table" rid="T3">Table 3</xref>). The predicted effect of missense variants on 
protein structure are given in Table 2.</p>
<p>Moreover, based on the analysis of the sequence of 
lysine tRNA and aspartate tRNA genes, the A8302G
variant was found in the former gene in two brothers in 
a pedigree (<xref ref-type="fig" rid="F3">Fig .3A</xref>) and the T7572C variant was found
in the latter gene in two brothers in another pedigree
(<xref ref-type="fig" rid="F3">Fig .3B</xref>). Variants C15904T and G15928A were also 
found in two infants in the threonine and tyrosine tRNA 
genes, respectively. </p>
<fig id="F2" orientation="portrait" position="float">
<label>Fig.2</label>
<caption>
<p>Chromatogram of <italic>C9227G</italic> as a novel heteroplasmic variant in the 
<italic>Mt. Cytochrome C oxidase</italic> gene. </p>
</caption>
<graphic xlink:href="Cell-J-20-333-g02"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Fig.3</label>
<caption>
<p> Pedigree diagram. A. Pedigree of a family with a A8302G variant in 
siblings and B. Pedigree of a family with a T7572C variant in siblings. </p>
</caption>
<graphic xlink:href="Cell-J-20-333-g03"></graphic>
</fig>
<table-wrap id="T3" orientation="portrait" position="float">
<label>Table 3</label>
<caption>
<p>Frequency distribution of Mt-Cytochrome C oxidase variants in pompe and controls</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<th colspan="9" rowspan="1">
<hr/>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1">Infant/Adult</th>
<th colspan="1" rowspan="1">Nucleotide</th>
<th colspan="1" rowspan="1">Locus</th>
<th colspan="1" rowspan="1">Amino acid change</th>
<th colspan="1" rowspan="1">R/N.R</th>
<th colspan="1" rowspan="1">Hm/Ht</th>
<th colspan="1" rowspan="1">Pompe</th>
<th colspan="1" rowspan="1">Control</th>
<th colspan="1" rowspan="1">P value</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1">+</th>
<th colspan="1" rowspan="1">+</th>
<th colspan="1" rowspan="1"></th>
</tr>
<tr>
<th colspan="9" rowspan="1">
<hr/>
</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Adult</td>
<td colspan="1" rowspan="1">A7933G</td>
<td colspan="1" rowspan="1"> Cyto co2</td>
<td colspan="1" rowspan="1">p.L116L</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0.388</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C7939T</td>
<td colspan="1" rowspan="1">Cyto co2</td>
<td colspan="1" rowspan="1">p.F118F</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">A8170G</td>
<td colspan="1" rowspan="1"> Cyto co2</td>
<td colspan="1" rowspan="1">p.Gln195Gln</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">T9581C</td>
<td colspan="1" rowspan="1">Cyto co3</td>
<td colspan="1" rowspan="1">p.Asn125Asn</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">G9986A</td>
<td colspan="1" rowspan="1">Cyto co3</td>
<td colspan="1" rowspan="1">p.Gly260Gly</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0.388</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Infant</td>
<td colspan="1" rowspan="1">T7645C</td>
<td colspan="1" rowspan="1">MT co2</td>
<td colspan="1" rowspan="1">p.L20L</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0.388</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">G7805A</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.Val74IL</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">G7859A</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.D92N</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">T7861C</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.D92D</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0.388</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C7945T</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.S120S</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C7990A</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.L135L</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">A8014T</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.V143V</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C8137T</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.F184F</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">0.520</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">G8206A</td>
<td colspan="1" rowspan="1">MT CO2</td>
<td colspan="1" rowspan="1">p.Met207Met</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">0.990</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C9227G</td>
<td colspan="1" rowspan="1">Cyto co3</td>
<td colspan="1" rowspan="1">p.Ala7Ala</td>
<td colspan="1" rowspan="1">N.R</td>
<td colspan="1" rowspan="1">h.t</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">A9336G</td>
<td colspan="1" rowspan="1">Cyt co3</td>
<td colspan="1" rowspan="1">p.Met44Val</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">T9530C</td>
<td colspan="1" rowspan="1">Cyto co3</td>
<td colspan="1" rowspan="1">p.P108P</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0.388</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">C9776T</td>
<td colspan="1" rowspan="1">cyto co3</td>
<td colspan="1" rowspan="1">p.Asp190Asp</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">T9949G</td>
<td colspan="1" rowspan="1">Cyto co3</td>
<td colspan="1" rowspan="1">p.Val248Gly</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">T9963G</td>
<td colspan="1" rowspan="1">MT-Co3</td>
<td colspan="1" rowspan="1">p.Tyr253Asp</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Both</td>
<td colspan="1" rowspan="1">G8269A</td>
<td colspan="1" rowspan="1">MT-CO2</td>
<td colspan="1" rowspan="1">p.X228X</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">T9540C</td>
<td colspan="1" rowspan="1">cyto co3</td>
<td colspan="1" rowspan="1">p.L112L</td>
<td colspan="1" rowspan="1">R</td>
<td colspan="1" rowspan="1">Hm</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">0.219</td>
</tr>
<tr>
<th colspan="9" rowspan="1">
<hr/>
</th>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>R and N.R; Denote reported and not reported, respectively and Hm and Ht; Denotes homoplasmy and heteroplasmy, respectively.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>PD is a heterogeneous neuromuscular disorder. Patients 
suffer from myopathy, hypotonia and other neuromuscular 
manifestations (<xref ref-type="bibr" rid="B5">5</xref>). Some tissues such as the nerve and 
muscle are more susceptible to mitochondrial dysfunction 
since these tissues are highly dependent on oxidative 
phosphorylation (<xref ref-type="bibr" rid="B10">10</xref>). According to previous studies, 
mitochondrial abnormality has been observed in PD 
patients (<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B21">21</xref>). It is therefore possible that mitochondrial 
variants have a secondary role in PD. In this study, <italic>MT-ATP6/
8</italic> and <italic>Cytochrome C oxidase</italic> genes of 28 PD patients 
were screened. The last complex in the mitochondria, <italic>MT-ATP 
synthase</italic>, plays an important role in the production of 
ATP. It has 14 subunits, of which 2, namely <italic>MT-ATP6/8 </italic>
are encoded by mtDNA (<xref ref-type="bibr" rid="B21">21</xref>). Variants in these genes may
result in ATP production impairment in some vulnerable 
tissues such as the muscle (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>The role of complex V variants has already been seen
in the increase of free radicals. They can affect gene
expression as a secondary factor. In these genes, some 
amino acids are conserved and any change could be 
potentially pathogenic (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Fourteen variants were 
found in <italic>MT-ATP6/8</italic> of which three were novel. One was 
a non-synonymous variant, however, it had a predicted
benign effect on protein structure.</p>
<p><italic>MT-ATP6/8</italic> expression decreased in the classic group 
and the number of variants in this group was more 
than the non-classic group. These are consistent with 
the severity of symptoms in the classic group. The
missense variants A8502T, G9039A and G9055A replace 
Asparagine to Isoleucine, Methionine to Isoleucine 
and Alanine to Threonine respectively which all have a 
predicted damaging effect on protein structure. A8502T 
was reported by Gurses in 44 patients with Epilepsy 
(<xref ref-type="bibr" rid="B25">25</xref>). Asparagine is a polar amino acid which can form
hydrogen bonds and acts as a neurotransmitter with
Glutamate, while leucine is a non-polar and hydrophobic
amino acid. This replacement may thus affect protein
function as predicted by Polyphen 2. </p>
<p>With respect to G8697A, methionine is a conserved 
amino acid. It has a sulfur in its structure that tends 
to form beta-sheets and despite owning hydrophobic 
properties, it can interact with some electrophilic regions. 
In contrast, isoleucine participates in alpha-helix structure 
and plays a role in ligand binding to protein. Such a 
replacement may change the structure and function of 
<italic>MT-ATP6</italic>. This variant was also observed in other studies 
(<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). <italic>MT-ATP6/8</italic> genes were also studied in other 
neurodegenerative diseases such as Huntington (<xref ref-type="bibr" rid="B26">26</xref>), 
Friedreich’s ataxia and multiple sclerosis (MS) (<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>The C8684T variant in MT-ATP6 changes threonine 
to isoleucine. The former is a polar amino acid while the 
latter is non-polar. This change may affect the tertiary 
structure of the protein and its interaction with the ATP 
molecule. This variant was also observed in ataxia and 
autism (<xref ref-type="bibr" rid="B29">29</xref>). The C8684T was observed in MS and 
Huntington’s (<xref ref-type="bibr" rid="B23">23</xref>), and G8697A in MS (<xref ref-type="bibr" rid="B23">23</xref>) and ataxia 
telangiectasia (<xref ref-type="bibr" rid="B27">27</xref>). The C8562T is a synonymous 
variant which has been reported in patients with 
ataxia (<xref ref-type="bibr" rid="B29">29</xref>). A8456C and C8406T have benign effects. 
A8860G was found in 85.71% of patients. In addition, 
the variants G8697A and A8701G were previously 
reported in cardiomyopathy. This variant has also been 
reported in neurodegenerative diseases (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>It is possible that the cardiomyopathy observed in PD 
patients is the result of the presence of these variants, by 
dysregulating <italic>Mt.ATPase6/8</italic> 
expression that was observed 
in this study. According to the previous study promoters 
are located in the D-loop region, this area is a hot spot 
therefor D-loop variants may change the sequence of 
promoters and binding affinity of transcription factors to 
enhancer or silencer elements (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). It seems that 
these variants along with other genetic and environmental 
factors are involved in development of PD. </p>
<p>Mitochondrial DNA encodes 3 subunits for 
cytochrome C oxidase. It is the last enzyme in the 
mitochondrial respiratory chain and is responsible for 
electron transfer from the cytochrome to oxygen (<xref ref-type="bibr" rid="B31">31</xref>). 
Impairment of cytochrome C oxidase is clinically highly 
heterogeneous. It starts at any age and includes a diverse 
range of myopathy to severe multi-organ involvement 
(<xref ref-type="bibr" rid="B32">32</xref>).Genetic defects that affect the structure and function 
of this gene are usually severe and often lead to fatal 
metabolic disorders. Such disorders usually occur before 
the age of 2 and involve tissues such as the heart, muscle 
and liver, however, its manifestation in adulthood is with
less severity. Severity of this disorder can vary even in
family members. </p>
<p>In the case of early onset cardiac muscle involvement 
is usually associated with hypertrophic cardiomyopathy, 
however, in late onset cases, myopathy and hypotonia are 
observed (<xref ref-type="bibr" rid="B33">33</xref>). It seems that the pattern of manifestations 
associated with <italic>MT-cytochrome C oxidase</italic> is similar to 
PD. Variants T9540C, T7645C and G8269A observed 
in this study were identical to those found in the study 
by Mkaouar-Rebai et al. (<xref ref-type="bibr" rid="B34">34</xref>) on patients with myopathy. 
These variants are likely to be related to myopathy and 
hypotonia symptoms of PD. The two variants T9949G and 
T9963G change valine to glycine and tyrosine to aspartic 
acid respectively. Polyphen 2 predicted these variants to 
have a damaging effect on protein structure. Both variants 
were in the classic group, thus suggesting that they may 
lead to more severe phenotypes in this group. </p>
<p>The observed A8302G variant in lysine tRNA has 
been previously reported in encephalopathy (<xref ref-type="bibr" rid="B35">35</xref>). Also, 
Govindaraj et al. (<xref ref-type="bibr" rid="B36">36</xref>) reported this mutation in three 
patients with Madras motor neuron disease (MMND).</p>
<p>The variant T7572C located on the T arm of the gene 
encoding aspartate tRNA was previously reported by 
Reddy et al. (<xref ref-type="bibr" rid="B37">37</xref>) in myelodysplastic syndrome, however, 
Li et al. (<xref ref-type="bibr" rid="B38">38</xref>) found it as a neutral polymorphism, showing 
that this variant did not affect the secondary structure of 
the corresponding tRNA by using RNA fold.</p>
<p>G15928A, which is located at the anticodon stem of 
the tRNAThr, is shown to be a neutral polymorphism 
(<xref ref-type="bibr" rid="B38">38</xref>). The C15904T variant is also shown to be a 
polymorphism which occurs in the general population 
with low frequency (<xref ref-type="bibr" rid="B39">39</xref>). The C15904T and G15928A 
variants were observed in patients with encephalopathy 
by Houshmand et al. (<xref ref-type="bibr" rid="B40">40</xref>). Overall, validation of the 
function of each variant is recommended.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusion</title>
<p>The extent of mitochondrial involvement in the classic 
group was more severe than the non-classic group. 
According to these findings, it seems that mtDNA 
variants have a secondary role in PD. Understandingthe role of mitochondria in the pathogenesis of PD may 
potentially lead to the development of new therapeutic 
strategies. </p>
</sec>
</body>
<back>
<ack>
<p>We thank all the participants in this study. This study 
was funded by Tehran University of Medical Sciences, 
Tehran, Iran (Grant Number: 23162). The authors declare 
no conflict of interest. 
</p>
</ack>
<bio id="d35e1515">
<title>Author’s Contributions </title>
<p>F.B., S.M.A., M.H., M.H.M.; Conceptualization, 
investigation, methodology, supervision, validation, 
visualization, writing-review and editing. F.B.; Data 
curation. F.B., M.H.; Formal analysis. F.B., S.M.A., 
M.H.; Project administration. F.B., S.M.A.; Software and 
writing-original draft. All authors read and approved the 
final manuscript. </p>
</bio>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobson Webb</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Proia</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Thurberg</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Banugaria</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prater</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Kishnani</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature</article-title>
<source/>Mol Genet Metab
          <year>2012</year>
<volume>106</volume>
<issue>4</issue>
<fpage>462</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="pmid">22664150</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pittis</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Donnarumma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Montalvo</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Dominissini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kroos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rosano</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease</article-title>
<source/>Hum Mutat
          <year>2008</year>
<volume>29</volume>
<issue>6</issue>
<fpage>E27</fpage>
<lpage>E36</lpage>
<pub-id pub-id-type="pmid">18429042</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishnani</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Beckemeyer</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Mendelsohn</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management</article-title>
<source/>Am J Med Genet C Semin Med Genet
          <year>2012</year>
<volume>160C</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">22253049</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishnani</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Bali</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Byrne</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>LE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pompe disease diagnosis and management guideline</article-title>
<source/>Genet Med
          <year>2006</year>
<volume>8</volume>
<issue>5</issue>
<fpage>267</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="pmid">16702877</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishnani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hwu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nicolino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Corzo</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease</article-title>
<source/>Pediatrics
          <year>2006</year>
<volume>148</volume>
<issue>5</issue>
<fpage>671</fpage>
<lpage>676</lpage>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuller</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wenninger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Strigl-Pill</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schoser</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Toward deconstructing the phenotype of late-onset Pompe disease</article-title>
<source/>Am J Med Genet C Semin Med Genet
          <year>2012</year>
<volume>160C</volume>
<issue>1</issue>
<fpage>80</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">22253010</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nardin</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Johns</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction and neuromuscular disease</article-title>
<source/>Muscle Nerve
          <year>2001</year>
<volume>24</volume>
<issue>2</issue>
<fpage>170</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">11180201</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Kubacka</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chinnery</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Lightowlers</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Turnbull</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA</article-title>
<source/>Nat Genet
          <year>1999</year>
<volume>23</volume>
<issue>2</issue>
<fpage>147</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="pmid">10508508</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Schmittgen</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>
<source/>Methods
          <year>2001</year>
<volume>25</volume>
<issue>4</issue>
<fpage>402</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="pmid">11846609</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiMauro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bonilla</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schon</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Mitochondria in neuromuscular disorders</article-title>
<source/>Biochim Biophys Acta
          <year>1998</year>
<volume>1366</volume>
<issue>1-2</issue>
<fpage>199</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="pmid">9714805</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engel</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations</article-title>
<source/>Mayo Clin Proc
          <year>1968</year>
<volume>43</volume>
<issue>4</issue>
<fpage>233</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="pmid">4886322</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hudgson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fulthorpe</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>The pathology of type II skeletal muscle glycogenosis A light and electron-microscopic study</article-title>
<source/>J Pathol
          <year>1975</year>
<volume>116</volume>
<issue>3</issue>
<fpage>139</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="pmid">172619</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verity</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Infantile Pompe’s disease, lipid storage, and partial carnitine deficiency</article-title>
<source/>Muscle Nerve
          <year>1991</year>
<volume>14</volume>
<issue>5</issue>
<fpage>435</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="pmid">1870635</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandeza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fernandezb</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cerverac</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Teijeiraa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Teijeiroa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Domınguezd</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adult glycogenosis II with paracrystalline mitochondrial inclusions and Hirano bodies in skeletal muscle</article-title>
<source/>Neuromuscul Disord
          <year>1999</year>
<volume>9</volume>
<issue>3</issue>
<fpage>136</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="pmid">10382906</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laforet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nicolino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eymard</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Puech</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Caillaud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Poenaru</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation</article-title>
<source/>Neurology
          <year>2000</year>
<volume>55</volume>
<issue>8</issue>
<fpage>1122</fpage>
<lpage>1128</lpage>
<pub-id pub-id-type="pmid">11071489</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selak</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>de Chadarevian</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Melvin</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Grover</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Salganicoff</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kaye</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>Mitochondrial activity in Pompe’s disease</article-title>
<source/>Pediatr Neurol
          <year>2000</year>
<volume>23</volume>
<issue>1</issue>
<fpage>54</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">10963971</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thurberg</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Lynch Maloney</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vaccaro</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Afonso</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Bossen</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease</article-title>
<source/>Lab Invest
          <year>2006</year>
<volume>86</volume>
<issue>12</issue>
<fpage>1208</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="pmid">17075580</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewandowska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wierzba-Bobrowicz</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rola</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Modzelewska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stępień</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ługowska</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathology of skeletal muscle cells in adult-onset glycogenosis type II (Pompe disease): ultrastructural study</article-title>
<source/>Folia Neuropathol
          <year>2008</year>
<volume>46</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="pmid">18587706</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herzog</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hartung</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reuser</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hermanns</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Runz</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Karabul</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A cross-sectional single-centre study on the spectrum of Pompe disease, German patients:molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations</article-title>
<source/>Orphanet J Rare Dis
          <year>2012</year>
<volume>7</volume>
<fpage>35</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">22676651</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoogeveen-Westerveld</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van der ploeg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reuser</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>The genotype-phenotype correlation in Pompe disease</article-title>
<source/>Am J Med Genet C Semin Med Genet
          <year>2012</year>
<volume>160C</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">22253258</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attardi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schatz</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Biogenesis of mitochondria</article-title>
<source/>Annu Rev Cell Biol
          <year>1988</year>
<volume>4</volume>
<fpage>289</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="pmid">2461720</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tzen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>HF</given-names>
</name>
</person-group>
<article-title>Sequence polymorphism in the coding region of mitochondrial genome encompassing position 8389-8865</article-title>
<source/>Forensic Sci Int
          <year>2001</year>
<volume>120</volume>
<issue>3</issue>
<fpage>204</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="pmid">11473803</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghaffarpour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mahdian</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fereiduni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kamalidehghan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Moazami</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Houshmand</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients</article-title>
<source/>Cancer Cell Int
          <year>2014</year>
<volume>14</volume>
<issue>1</issue>
<fpage>21</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">24588805</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tzen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>TY</given-names>
</name>
</person-group>
<article-title>Evolutionalanalysis in determining pathogenic versus nonpathogenic mutations of ATPase 6 in human mitochondriopathy</article-title>
<source/>Ann N Y Acad Sci
          <year>2005</year>
<volume>1042</volume>
<fpage>19</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">15965041</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurses</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Azakli</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alptekin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cakiris</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abaci</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Arikan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial DNA profiling via genomic analysis in mesial temporal lobe epilepsy patients with hippocampal sclerosis</article-title>
<source/>Gene
          <year>2014</year>
<volume>538</volume>
<issue>2</issue>
<fpage>323</fpage>
<lpage>3277</lpage>
<pub-id pub-id-type="pmid">24440288</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasraie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Houshmand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banoei</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ahari</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Panahi</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Shariati</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Investigation of tRNA(Leu/Lys) and ATPase 6 genes mutations in Huntington’s disease</article-title>
<source/>Cell Mol Neurobiol
          <year>2008</year>
<volume>28</volume>
<issue>7</issue>
<fpage>933</fpage>
<lpage>938</lpage>
<pub-id pub-id-type="pmid">18386172</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>KulawIec</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
</person-group>
<article-title>Cancer cell mitochondria confer apoptosis resistance and promote metastasis</article-title>
<source/>Cancer Biol Ther
          <year>2009</year>
<volume>8</volume>
<issue>14</issue>
<fpage>1378</fpage>
<lpage>1385</lpage>
<pub-id pub-id-type="pmid">19556849</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Houshmand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kasraie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bahar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shafa Shariat Panahi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Point mutations on mitochondrial DNA in Iranian patients with friedreich’s ataxia</article-title>
<source/>Iran J Child Neurol
          <year>2007</year>
<volume>2</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>45</lpage>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houshmand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kasraie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Etemad Ahari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bahar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zamani</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Investigation of tRNA and ATPase 6/8 gene mutations in Iranian ataxia telangiectasia patients</article-title>
<source/>Arch Med Sci
          <year>2011</year>
<volume>7</volume>
<issue>3</issue>
<fpage>523</fpage>
<lpage>527</lpage>
<pub-id pub-id-type="pmid">22295039</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houshmand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Montazeri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuchekian</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Noohi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nozar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zamani</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Is 8860 variation a rare polymorphism or associated as a secondary effect in HCM disease?</article-title>
<source/>Arch Med Sci
          <year>2011</year>
<volume>7</volume>
<issue>2</issue>
<fpage>242</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">22291763</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siskova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wihelm</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The effects of hyperoxia, hypoxia, and ischemia/ reperfusion on the activity of cytochrome oxidase from the rat retina</article-title>
<source/>Physiol Res
          <year>2001</year>
<volume>50</volume>
<issue>3</issue>
<fpage>267</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">11521737</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoubridge</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Cytochrome c oxidase deficiency</article-title>
<source/>Am J Med Genet
          <year>2001</year>
<volume>106</volume>
<issue>1</issue>
<fpage>46</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="pmid">11579424</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pecina</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Houstkova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hansíkova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zeman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Houstek</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genetic defects of cytochrome c oxidase assembly</article-title>
<source/>Physiol Res
          <year>2004</year>
<volume>53</volume>
<issue>Suppl 1</issue>
<fpage>S213</fpage>
<lpage>S223</lpage>
<pub-id pub-id-type="pmid">15119951</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mkaouar-Rebai</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ben Mahmoud</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chamkha</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chabchoub</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kammoun</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hachicha</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel MT-CO2 m.8249G&gt;A pathogenic variation and the MT-TW m.5521G&gt;A mutation in patients with mitochondrial myopathy</article-title>
<source/>Mitochondrial DNA
          <year>2014</year>
<volume>25</volume>
<issue>5</issue>
<fpage>394</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="pmid">23841600</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sternberg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chatzoglou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Laforet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fayet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jardel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Blondy</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders</article-title>
<source/>Brain
          <year>2001</year>
<volume>124</volume>
<issue>Pt 5</issue>
<fpage>984</fpage>
<lpage>994</lpage>
<pub-id pub-id-type="pmid">11335700</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Govindaraj</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nalini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sharath</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Tamang</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial DNA variations in Madras motor neuron disease</article-title>
<source/>Mitochondrion
          <year>2013</year>
<volume>13</volume>
<issue>6</issue>
<fpage>721</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="pmid">23419391</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Shetty</surname>
<given-names>VT</given-names>
</name>
<name>
<surname>Dutt</surname>
<given-names>D</given-names>
</name>
<name>
<surname>York</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mundle</surname>
<given-names>SD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes</article-title>
<source/>Br J Haematol
          <year>2002</year>
<volume>116</volume>
<issue>3</issue>
<fpage>564</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">11849212</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>YR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial transfer RNA mutations and male infertility</article-title>
<source/>Biomed Res
          <year>2017</year>
<volume>28</volume>
<issue>11</issue>
<fpage>4908</fpage>
<lpage>4912</lpage>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Ouweland</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Bruining</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Lindhout</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wit</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Veldhuyzen</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Maassen</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Mutations in mitochondrial tRNA genes: non-linkage with syndromes of Wolfram and chronic progressive external ophthalmoplegia</article-title>
<source/>Nucleic Acids Res
          <year>1992</year>
<volume>20</volume>
<issue>4</issue>
<fpage>679</fpage>
<lpage>682</lpage>
<pub-id pub-id-type="pmid">1542564</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houshmand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Holme</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Oldfors</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tulinius</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Automatic sequencing of mitochondrial tRNA genes in patients with mitochondrial encephalomyopathy</article-title>
<source/>Biochim Biophys Acta
          <year>1994</year>
<volume>122</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>55</lpage>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>